Literature DB >> 15734009

Sclerochoroidal calcification in a patient with classic Bartter's syndrome.

Hong Sun1, Hakan Demirci, Carol L Shields, Jerry A Shields.   

Abstract

PURPOSE: To report sclerochoroidal calcification in a patient with classic Bartter's syndrome.
DESIGN: Observational case report.
METHODS: A 42-year-old woman with a 26-year history of classic Bartter's syndrome was found to have bilateral fundus tumors. The patient presented initially with quivering lips and hand stiffness at age 6 years but was not diagnosed until age 16 years. Treatment included magnesium and potassium supplementation and Amiloride therapy.
RESULTS: On ocular examination, there were multifocal, yellow-white, geographic, solid choroidal lesions along the superior and inferior retinal vascular arcades in both eyes. Ultrasonography showed echogenic, placoid calcified lesions at the level of the sclera and choroid, consistent with bilateral sclerochoroidal calcification.
CONCLUSIONS: Sclerochoroidal calcification can be associated with classic Bartter's syndrome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15734009     DOI: 10.1016/j.ajo.2004.07.054

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  3 in total

Review 1.  The long-term complications of the inherited tubulopathies: an adult perspective.

Authors:  Maryam Khosravi; Stephen B Walsh
Journal:  Pediatr Nephrol       Date:  2014-02-25       Impact factor: 3.714

2.  The Bartter-Gitelman Spectrum: 50-Year Follow-up With Revision of Diagnosis After Whole-Genome Sequencing.

Authors:  Mark Stevenson; Alistair T Pagnamenta; Heather G Mack; Judith Savige; Edoardo Giacopuzzi; Kate E Lines; Jenny C Taylor; Rajesh V Thakker
Journal:  J Endocr Soc       Date:  2022-05-15

3.  Stones, bones, groans, thrones, and psychiatric overtones: Systemic associations of sclerochoroidal calcification.

Authors:  Jordan A Sugarman; Alexzandra M Douglass; Emil Anthony T Say; Carol L Shields
Journal:  Oman J Ophthalmol       Date:  2017 Jan-Apr
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.